Primary central nervous system lymphoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:


*The understanding of the pathogenesis of primary central nervous system lymphoma is quite limited as the CNS is devoid of any B-cells.<ref name="pmid18976024">{{cite journal| author=Bhagavathi S, Wilson JD| title=Primary central nervous system lymphoma. | journal=Arch Pathol Lab Med | year= 2008 | volume= 132 | issue= 11 | pages= 1830-4 | pmid=18976024 | doi=10.1043/1543-2165-132.11.1830 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18976024  }} </ref>
*The understanding of the pathogenesis of primary central nervous system lymphoma is quite limited as the CNS is devoid of any B-cells.<ref name="pmid18976024">{{cite journal| author=Bhagavathi S, Wilson JD| title=Primary central nervous system lymphoma. | journal=Arch Pathol Lab Med | year= 2008 | volume= 132 | issue= 11 | pages= 1830-4 | pmid=18976024 | doi=10.1043/1543-2165-132.11.1830 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18976024  }} </ref>
*[[EBV]] is almost always associated with primary CNS lymphoma in immunodeficient individuals, and latent EBV infection of B-cells leads to it's immortalization and to CNS tropism. In immunocompetent individuals, the B-cells infected with EBV are held in check by T-cells, and with the severity of immunosuppression, T cells gradually fall, leading to the B-cell proliferation and dissemination.<ref name="pmid18976024">{{cite journal| author=Bhagavathi S, Wilson JD| title=Primary central nervous system lymphoma. | journal=Arch Pathol Lab Med | year= 2008 | volume= 132 | issue= 11 | pages= 1830-4 | pmid=18976024 | doi=10.1043/1543-2165-132.11.1830 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18976024  }} </ref>


==Genetics==
==Genetics==

Revision as of 23:23, 8 April 2019

Primary central nervous system lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary Central Nervous System Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary central nervous system lymphoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary central nervous system lymphoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary central nervous system lymphoma pathophysiology

CDC on Primary central nervous system lymphoma pathophysiology

Primary central nervous system lymphoma pathophysiology in the news

Blogs on Primary central nervous system lymphoma pathophysiology

Directions to Hospitals Treating Primary central nervous system lymphoma

Risk calculators and risk factors for Primary central nervous system lymphoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Primary central nervous system lymphoma may originate from a germinal center to an early postgerminal center in a secondary lymphoid organ, which may be capable of further maturation steps.[1] EBV is almost always associated with primary CNS lymphoma in immunodeficient individuals, and latent EBV infection of B-cells leads to it's immortalization and to CNS tropism. In immunocompetent individuals, the B-cells infected with EBV are held in check by T-cells, and with the severity of immunosuppression, T cells gradually fall, leading to the B-cell proliferation and dissemination.[2] Genes involved in the pathogenesis of primary central nervous system lymphoma include IG, BCL6, CD95, PAX5, and PIM1.[3] Primary central nervous system lymphoma is highly associated with Epstein-Barr virus (EBV) infection (> 90%) in immunodeficient patients (such as those with AIDS and iatrogenically immunosuppressed).[4] Primary central nervous system lymphoma presents as a solitary or multiple, well circumscribed, greater than 2 cm in diameter, well-defined or infiltrating mass lesion/s that can arise in the cortex, white matter, or deep grey matter (more common in low-grade lesions).[5][2] On gross pathology, the lesions could be brownish, gray-tan, or yellow, firm, homogenous, centrally necrotic with areas of hemorrhage.[2] On microscopic histopathological analysis, primary central nervous system lymphoma is characterized by accumulation of large atypical mononuclear cells around small calibre vascular channels with invasion of the walls of some vessels. The atypical cells have large round, oval and angulated hyperchromatic and vesicular nuclei, and a narrow rim of pale cytoplasm. An occasional mitotic figure is noted.[4][6] Primary central nervous system lymphoma is demonstrated by positivity to tumor markers, including B lymphocyte markers, such as CD19, CD20, CD79a, Ki-67, GFAP, BCL-2, and BCL-6.[2][6][7][8]

Pathogenesis

  • Primary central nervous system lymphoma may originate from a germinal center to an early postgerminal center in a secondary lymphoid organ, which may be capable of further maturation steps.[1]
  • The understanding of the pathogenesis of primary central nervous system lymphoma is quite limited as the CNS is devoid of any B-cells.[2]
  • EBV is almost always associated with primary CNS lymphoma in immunodeficient individuals, and latent EBV infection of B-cells leads to it's immortalization and to CNS tropism. In immunocompetent individuals, the B-cells infected with EBV are held in check by T-cells, and with the severity of immunosuppression, T cells gradually fall, leading to the B-cell proliferation and dissemination.[2]

Genetics

  • Development of primary central nervous system lymphoma is the result of multiple genetic mutations.
  • Genes involved in the pathogenesis of primary central nervous system lymphoma include:[3]

Associated Conditions

Gross Pathology

  • Primary central nervous system lymphoma presents as a solitary or multiple, well circumscribed, greater than 2 cm in diameter, well-defined or infiltrating mass lesion/s that can arise in the cortex, white matter, or deep grey matter (more common in low-grade lesions).[5][2]
  • On gross pathology, the lesions could be brownish, gray-tan, or yellow, firm, homogenous, centrally necrotic with areas of hemorrhage.[2]
  • The lesion is mainly located at supratentorial level, usually in the periventricular regions, infiltrating the corpus callosum and the basal ganglia.[9]
  • Multiple lesions are reported in 38%–55% of non-AIDS primary CNS lymphomas. Multifocal intraparenchymal lesions, without a dural involvement, are very rare. Frontal lobe is affected in 20%–43% of primary CNS lymphoma. Other sites iclude brain stem, cerebellum, leptomeninges, spinal cord, and eyes.
  • They may demonstrate areas of necrosis, especially in immunodeficient patients.
  • Origin of malignant cells is not well understood as intra-axial CNS does not have lymphatic system.[5]

Gallery

Microscopic Pathology

  • The vast majority (>90%) of primary central nervous system lymphoma are B-cell in origin: diffuse large B-cell lymphoma and high-grade Burkitt-like B-cell lymphoma.[5]
  • Malignant cells tend to accumulate around blood vessels (angiocentric pattern).[2]
  • Low-grade tumors are more frequently T-cell in origin.[5]
  • On microscopic histopathological analysis, primary central nervous system lymphoma is characterized by accumulation of large atypical mononuclear cells around small calibre vascular channels with invasion of the walls of some vessels. The atypical cells have large round, oval and angulated hyperchromatic and vesicular nuclei, and a narrow rim of pale cytoplasm. An occasional mitotic figure is noted.[4][6]

Gallery

Immunohistochemistry

Primary central nervous system lymphoma is demonstrated by positivity to tumor markers, including B lymphocyte markers, such as:[6][7][8][2]

Gallery

References

  1. 1.0 1.1 PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS IN THE NEUROLOGICAL PRACTICE. file:///C:/Users/Owner/Downloads/psyneur_2014_1_2_8.pdf. Accessed on February 19, 2016
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 Bhagavathi S, Wilson JD (2008). "Primary central nervous system lymphoma". Arch Pathol Lab Med. 132 (11): 1830–4. doi:10.1043/1543-2165-132.11.1830. PMID 18976024.
  3. 3.0 3.1 Ferreri, A. J. M. (2011). "How I treat primary CNS lymphoma". Blood. 118 (3): 510–522. doi:10.1182/blood-2011-03-321349. ISSN 0006-4971.
  4. 4.0 4.1 4.2 4.3 4.4 Primary central nervous system lymphoma. Wikipedia 2016. https://en.wikipedia.org/wiki/Primary_central_nervous_system_lymphoma. Accessed on February 18, 2016
  5. 5.0 5.1 5.2 5.3 5.4 Pathology of primary central system lymphoma. Dr Amir Rezaee and A.Prof Frank Gaillard et al. Radiopaedia 2016. http://radiopaedia.org/articles/primary-cns-lymphoma. Accessed on February 18, 2016
  6. 6.0 6.1 6.2 6.3 6.4 CNS lymphoma (primary). A.Prof Frank Gaillard. Radioapaedia 2016. http://radiopaedia.org/cases/cns-lymphoma-primary. Accessed on February 23, 2016
  7. 7.0 7.1 Haldorsen, Ingfrid S; Kråkenes, Jostein; Goplen, Anne K; Dunlop, Oona; Mella, Olav; Espeland, Ansgar (2008). "AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989–2003". BMC Cancer. 8 (1): 225. doi:10.1186/1471-2407-8-225. ISSN 1471-2407.
  8. 8.0 8.1 Yamanaka, Ryuya (2013). "Primary Central Nervous System Lymphoma − Recent Advance on Clinical Research". doi:10.5772/52757.
  9. Manenti, G.; Di Giuliano, F.; Bindi, A.; Liberto, V.; Funel, V.; Garaci, F. G.; Floris, R.; Simonetti, G. (2013). "A Case of Primary T-Cell Central Nervous System Lymphoma: MR Imaging and MR Spectroscopy Assessment". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/916348. ISSN 2090-6862.
  10. Image courtesy of Dr. A.Prof Frank Gaillard. Radiopaedia (original file here). Creative Commons BY-SA-NC


Template:WikiDoc Sources